A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine

NCT06754605 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus

Interventions

BIOLOGICAL: SCTV02
BIOLOGICAL: Placebo

Sponsor

Sinocelltech Ltd.